Low regional cerebral blood flow in burning mouth syndrome patients with depression

Bl, Liu; Yao, Hui; Xj, Zheng; Gh, Du; Xm, Shen; Ym, Zhou; Gy, Tang

doi:10.1111/odi.12322

Cited by 10 publications

(11 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study included participants with typical characteristics of BMS: age, 8,9,15 gender (the majority were female) 5,9,11,20 and tongue as most commonly affected area. 6,14 Those characteristics were equally present in both groups.…”

Section: Discussionmentioning

confidence: 99%

“…Paroxetine and sertraline were efficacious in nearly 70% of patients with BMS during 8‐week treatment . Cumulative proportion of paroxetine responders was 81% during 12‐week treatment …”

Section: Introductionmentioning

confidence: 98%

“…14 Cumulative proportion of paroxetine responders was 81% during 12-week treatment. 15 The aim of this study was to estimate efficacy of fluoxetine during six-month treatment on pain intensity and psychological factors in participants with BMS.…”

mentioning

confidence: 99%

See 2 more Smart Citations

The efficacy of fluoxetine in BMS—A cross‐over study

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 98%

See 1 more Smart Citation

The efficacy of fluoxetine in BMS—A cross‐over study

et al. 2018

View full text Add to dashboard Cite

show abstract

“…BMS patients have higher anxiety and depression scores. Also, it is widely accepted that pain is a somatic aspect of depression and anxiety worsens somatization [99][100][101][102][103][104][105][106][107][108][109][110][111][112][113] . Psychological conditions may play an important role in the modulation of pain perception.…”

Section: Psychogenic Causesmentioning

confidence: 99%

Burning Mouth Syndrome –Latest update

Tomattis¹,

Munerato²

2016

Int J Dentistry Res

View full text Add to dashboard Cite

Introduction: Burning mouth syndrome (BMS) is characterized by a recurrent daily burning sensation with no evidence lesions in the oral mucosa. It is accompanied by subjective dry mouth and dysgeusia. The tongue is the most commonly affected site, but the condition also affects other sites in the mouth. Its etiopathogeny is multifactorial and its diagnosis is made by exclusion. Objective: This article reviews the literature about the epidemiology, etiopathogeny, and diagnosis of BMS in the past 15 years. Articles were selected from PubMed/MEDLINE, and included clinical assays, case reports, and reviews. We found 509 articles, and only 136 were chosen. The key words were: burning mouth syndrome (BMS), review, etiopathogeny, diagnosis. Conclusions: BMS remains an important diagnostic challenge, though the disease is considered a neuropathy characterized by damage to trigeminal peripheral nervous fibers, which triggers central sensitization. In addition to BMS and secondary BMS, it seems relevant to include complicated BMS, in which symptoms persist despite the elimination of local and systemic causes. BMS should be investigated by a transdisciplinary team that will take into account all aspects active in the mental and physical dimensions of the condition, in the most detailed way. Therefore, QST, imaging investigations, various evaluation scales of mental health and of the impact of BMS on quality of life as well as the investigation of sleep disorders and changes in circadian rhythm could be useful tools in the development of treatment strategies based on findings and observing the characteristics of each BMS patient in light of specifics of diagnosis.

show abstract

“…To date, there is no clear evidence that there is dysfunction of central and/or peripheral nervous system in patients with BMS (3,4). There are 3 subgroups of BMS patients: subgroup with peripheral small diameter fiber neuropathy of intraoral mucosa (50-65%), subgroup with subclinical lingual, mandibular or trigeminal system pathology (20-25%), subgroup with presentation of central pain pattern which can be attributed to dysfunction of central dopaminergic or serotoninergic pathways (20-40%) (5). Functional studies using 6-(18F) fluorodopa (FDOPA) positron emission tomography in BMS patients have shown a dysfunction of striatal do-…”

Section: Introductionmentioning

confidence: 99%